These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2667542)

  • 1. Drug development in age-related memory disorders.
    Guez D
    Arch Gerontol Geriatr Suppl; 1989; 1():191-4. PubMed ID: 2667542
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials in memory disorders: objectives and methodology.
    Alperovitch A
    Arch Gerontol Geriatr Suppl; 1989; 1():207-14. PubMed ID: 2757734
    [No Abstract]   [Full Text] [Related]  

  • 3. Simvastatin enhances learning and memory independent of amyloid load in mice.
    Li L; Cao D; Kim H; Lester R; Fukuchi K
    Ann Neurol; 2006 Dec; 60(6):729-39. PubMed ID: 17192930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-associated memory impairment: diagnostic criteria and treatment strategies.
    Crook T; Bahar H; Sudilovsky A
    Int J Neurol; 1987-1988; 21-22():73-82. PubMed ID: 2980693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of cerebrovascular insufficiency. Their evaluation in a double-blind study].
    Feine-Haake G; Neiss A; Weinert W
    MMW Munch Med Wochenschr; 1975 Jun; 117(26):1131-2. PubMed ID: 817147
    [No Abstract]   [Full Text] [Related]  

  • 6. [Senile mental deterioration: therapeutic aspects].
    Tàmmaro AE; Noto M; Mulè M; Bonaccorso O
    Clin Ter; 1975 Jan; 72(1):55-65. PubMed ID: 776497
    [No Abstract]   [Full Text] [Related]  

  • 7. The neurobiology of aging.
    Kelly KM; Nadon NL; Morrison JH; Thibault O; Barnes CA; Blalock EM
    Epilepsy Res; 2006 Jan; 68 Suppl 1():S5-20. PubMed ID: 16386406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of age-related deficits in object recognition memory in rats with l-deprenyl.
    de Lima MN; Laranja DC; Caldana F; Bromberg E; Roesler R; Schröder N
    Exp Gerontol; 2005 Jun; 40(6):506-11. PubMed ID: 15935594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forgetting and remembering. A star-studded search for memory-enhancing drugs.
    Marshall E
    Science; 2004 Apr; 304(5667):36-8. PubMed ID: 15060299
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of drug effects in age-related memory disorders: clinical, theoretical, and psychometric considerations.
    Larrabee GJ; Crook T
    Psychopharmacol Bull; 1988; 24(4):515-22. PubMed ID: 3074312
    [No Abstract]   [Full Text] [Related]  

  • 11. [Testing of geriatric drugs by means of psychologic testing methods, based on the example of the Geriatric Pharmation].
    Simon WC
    Med Monatsschr; 1974 Jun; 28(6):262-4. PubMed ID: 4612319
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of drug efficacy in age-associated memory impairment.
    Crook TH
    Adv Neurol; 1990; 51():211-6. PubMed ID: 1967196
    [No Abstract]   [Full Text] [Related]  

  • 13. A logical approach to the clinical assessment of cerebro-active drugs.
    Wertheimer J
    Arch Gerontol Geriatr Suppl; 1989; 1():201-5. PubMed ID: 2757733
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicine's next level.
    Carmichael M
    Newsweek; 2004 Dec; 144(23):44-6, 49-50. PubMed ID: 15605719
    [No Abstract]   [Full Text] [Related]  

  • 15. Synaptic plasticity in early aging.
    Lynch G; Rex CS; Gall CM
    Ageing Res Rev; 2006 Aug; 5(3):255-80. PubMed ID: 16935034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion and exclusion clinical criteria to form homogeneous groups of patients in the therapeutic trials of a memory enhancing drug.
    Piette F
    Arch Gerontol Geriatr Suppl; 1989; 1():195-200. PubMed ID: 2757732
    [No Abstract]   [Full Text] [Related]  

  • 17. Amelioration of recognition memory impairment associated with iron loading or aging by the type 4-specific phosphodiesterase inhibitor rolipram in rats.
    de Lima MN; Presti-Torres J; Garcia VA; Guimarães MR; Scalco FS; Roesler R; Schröder N
    Neuropharmacology; 2008 Oct; 55(5):788-92. PubMed ID: 18619476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axel Unterbeck on memory, cognition and the development of CNS drugs. Interview by Steve Carney.
    Unterbeck A
    Drug Discov Today; 2005 Feb; 10(3):165-8. PubMed ID: 15708528
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
    Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
    Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verbal memory deficit in patients with schizophrenia: an important future target for treatment.
    Toulopoulouand T; Murray RM
    Expert Rev Neurother; 2004 Jan; 4(1):43-52. PubMed ID: 15853614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.